Advertisement

Index by author

March 01, 1993; Volume 264,Issue 3

A

  1. Aalkjaer, C

    1. Effects of ATP and related nucleotides on the tone of isolated rat mesenteric resistance arteries.
      B Juul, L Plesner and C Aalkjaer
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1234-1240;

  2. Abdel-Rahman, A A

    1. Direct evidence for selective involvement of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate.
      M M el-Mas and A A Abdel-Rahman
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1198-1205;

  3. Abels, B C

    1. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
      B C Abels, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1285-1292;

  4. Alaoui-Jamali, M A

    1. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
      M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;

  5. Amico, M C

    1. Effect of nonsteroidal anti-inflammatory drugs on withdrawal responses in guinea pig ileum after a brief exposure to morphine.
      P Valeri, L A Morrone, L Romanelli and M C Amico
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1028-1032;

  6. Ao, S

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  7. Apseloff, G

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  8. Archer, S

    1. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
      Q Jiang, A Seyed-Mozaffari, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1021-1027;

  9. Arentzen, C

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  10. Arneson-Rotert, L J

    1. Bicarbonate induces sensitization of cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
      M L Toews, L J Arneson-Rotert and S A Liewer
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1211-1217;

  11. Arrigoni, J

    1. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
      S Nishino, B Fruhstorfer, J Arrigoni, C Guilleminault, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1079-1084;

B

  1. Backer, C

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  2. Barturen, F

    1. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
      A Miralles, G Olmos, M Sastre, F Barturen, I Martin and J A Garcia-Sevilla
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1187-1197;

  3. Bathon, J M

    1. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
      D Proud, C J Reynolds, J Broomfield, D W Goldman and J M Bathon
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1124-1131;

  4. Batist, G

    1. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
      M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;

  5. Bell, W E

    1. Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: role of phosphodiesterase.
      B S Bender, W E Bell, S Taylor and P J Scarpace
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1381-1386;

  6. Bellan, J A

    1. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
      S Y Osei, R K Minkes, J A Bellan and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1104-1112;

  7. Bender, B S

    1. Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: role of phosphodiesterase.
      B S Bender, W E Bell, S Taylor and P J Scarpace
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1381-1386;

  8. Bergsbaken, C L

    1. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
      C L Bergsbaken, S L Sommers and P Y Law
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1474-1483;

  9. Bertz, R J

    1. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.
      P D Kroboth, R J Bertz and R B Smith
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1047-1055;

  10. Bickel, W K

    1. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
      C R Rush, S T Higgins, W K Bickel and J R Hughes
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1218-1226;

  11. Bidlack, J M

    1. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
      Q Jiang, A Seyed-Mozaffari, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1021-1027;

  12. Bon, C

    1. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
      C Mounier, M Hatmi, A Faili, C Bon and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1460-1467;

  13. Bourguignon, J J

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  14. Bradley, M E

    1. Adenosine-stimulated contraction in nonpregnant guinea pig myometrium does not involve cyclooxygenase.
      M E Bradley, K A Kuenzli and I L Buxton
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1033-1039;

  15. Branch, R A

    1. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
      B C Abels, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1285-1292;

  16. Brecht, K M

    1. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
      D M Maxwell, K M Brecht, B P Doctor and A D Wolfe
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1085-1089;

  17. Brien, J F

    1. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
      Z Liu, J F Brien, G S Marks, B E McLaughlin and K Nakatsu
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1432-1439;

  18. Broomfield, J

    1. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
      D Proud, C J Reynolds, J Broomfield, D W Goldman and J M Bathon
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1124-1131;

  19. Browning, M D

    1. Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.
      J A Firestone, G A Gerhardt, J F DeBernardis, J F McKelvy and M D Browning
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1206-1210;

  20. Buxton, I L

    1. Adenosine-stimulated contraction in nonpregnant guinea pig myometrium does not involve cyclooxygenase.
      M E Bradley, K A Kuenzli and I L Buxton
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1033-1039;

C

  1. Canton, H

    1. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
      M J Millan, J M Rivet, H Canton, S Le Marouille-Girardon and A Gobert
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1364-1376;

  2. Carr, D J

    1. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity.
      D J Carr, B M Gebhardt and D Paul
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1179-1186;

  3. CASTLE, NEIL A.

    1. Characterization of 4-Aminopyridine Block of the Transient Outward K+ Current in Adult Rat Ventricular Myocytes
      NEIL A. CASTLE and MARA T. SLAWSKY
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1450-1459;

  4. Cederbaum, A I

    1. Induction of liver cytochrome P4502E1 by pyrazole and 4-methylpyrazole in neonatal rats.
      D Wu and A I Cederbaum
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1468-1473;

  5. Centurioni, M G

    1. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
      M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;

  6. Chen, H

    1. Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
      H Chen, F G Hamel, G Siford and W C Duckworth
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1293-1298;

  7. Chiamvimonvat, N

    1. Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle.
      L Wang, N Chiamvimonvat and H J Duff
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1056-1062;

  8. Chiba, K

    1. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
      H Echizen, H Kawasaki, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1425-1431;

  9. Chiba, S

    1. Pharmacological analysis of vasodilation induced by extracellular adenosine 3',5'-cyclic monophosphate in the isolated and perfused canine coronary artery.
      T Nakane and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1253-1261;

  10. Cho, A K

    1. A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine.
      A K Cho, M Hiramatsu, D A Schmitz, H M Vargas and E M Landaw
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1401-1405;

  11. Colombo, G

    1. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
      K A Grant and G Colombo
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1241-1247;

  12. Crosland, R D

    1. Effect of arachidonic acid on twitch tension of the rat phrenic nerve-diaphragm.
      R D Crosland
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1311-1314;

D

  1. D'Ambra, T E

    1. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
      J E Kuster, J I Stevenson, S J Ward, T E D'Ambra and D A Haycock
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1352-1363;

  2. DeBernardis, J F

    1. Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.
      J A Firestone, G A Gerhardt, J F DeBernardis, J F McKelvy and M D Browning
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1206-1210;

  3. Dement, W C

    1. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
      S Nishino, B Fruhstorfer, J Arrigoni, C Guilleminault, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1079-1084;

  4. Doan, T N

    1. Role of lipid peroxidation in tert-butylhydroperoxide-induced inhibition of endothelial cell calcium signaling.
      S J Elliott, T N Doan and W P Schilling
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1063-1070;

  5. Doctor, B P

    1. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
      D M Maxwell, K M Brecht, B P Doctor and A D Wolfe
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1085-1089;

  6. Duan, D

    1. Potassium channel blocking properties of propafenone in rabbit atrial myocytes.
      D Duan, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1113-1123;

  7. Duckles, S P

    1. Acute effects of nicotine on rat mesenteric vasculature and tail artery.
      Z Li and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1305-1310;

  8. Duckworth, W C

    1. Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
      H Chen, F G Hamel, G Siford and W C Duckworth
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1293-1298;

  9. Duff, H J

    1. Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle.
      L Wang, N Chiamvimonvat and H J Duff
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1056-1062;

E

  1. Eager, S

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  2. Echizen, H

    1. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
      H Echizen, H Kawasaki, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1425-1431;

  3. Ehrhardt, J D

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  4. el-Mas, M M

    1. Direct evidence for selective involvement of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate.
      M M el-Mas and A A Abdel-Rahman
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1198-1205;

  5. Elliott, S J

    1. Role of lipid peroxidation in tert-butylhydroperoxide-induced inhibition of endothelial cell calcium signaling.
      S J Elliott, T N Doan and W P Schilling
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1063-1070;

  6. Enero, M A

    1. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
      S Nowicki, G Levin and M A Enero
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1377-1380;

  7. Epstein, M

    1. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
      T Takenaka, H Forster and M Epstein
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1154-1159;

F

  1. Faili, A

    1. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
      C Mounier, M Hatmi, A Faili, C Bon and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1460-1467;

  2. Fermini, B

    1. Potassium channel blocking properties of propafenone in rabbit atrial myocytes.
      D Duan, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1113-1123;
    2. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity.
      S Ranger, R Sheldon, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1160-1167;

  3. Fibiger, H C

    1. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
      G S Robertson, C S Tham, C Wilson, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1344-1351;

  4. Firestone, J A

    1. Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.
      J A Firestone, G A Gerhardt, J F DeBernardis, J F McKelvy and M D Browning
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1206-1210;

  5. Forster, H

    1. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
      T Takenaka, H Forster and M Epstein
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1154-1159;

  6. Franklin, P H

    1. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility.
      G Zhang, P H Franklin and T F Murray
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1415-1424;

  7. Fruhstorfer, B

    1. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
      S Nishino, B Fruhstorfer, J Arrigoni, C Guilleminault, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1079-1084;

  8. Furukawa, T

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

G

  1. Garcia-Sevilla, J A

    1. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
      A Miralles, G Olmos, M Sastre, F Barturen, I Martin and J A Garcia-Sevilla
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1187-1197;

  2. Gebhardt, B M

    1. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity.
      D J Carr, B M Gebhardt and D Paul
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1179-1186;

  3. George, F R

    1. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites.
      M C Ritz and F R George
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1333-1343;

  4. Gerber, N

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  5. Gerhardt, G A

    1. Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.
      J A Firestone, G A Gerhardt, J F DeBernardis, J F McKelvy and M D Browning
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1206-1210;

  6. Girten, B

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  7. Giuliani, S

    1. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
      A Lecci, S Giuliani, R Patacchini and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1327-1332;

  8. Gobaille, S

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  9. Gobert, A

    1. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
      M J Millan, J M Rivet, H Canton, S Le Marouille-Girardon and A Gobert
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1364-1376;

  10. Goldenberg, H

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  11. Goldman, D W

    1. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
      D Proud, C J Reynolds, J Broomfield, D W Goldman and J M Bathon
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1124-1131;

  12. Grant, K A

    1. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
      K A Grant and G Colombo
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1241-1247;

  13. Guilleminault, C

    1. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
      S Nishino, B Fruhstorfer, J Arrigoni, C Guilleminault, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1079-1084;

H

  1. Haile, D

    1. Tone-dependent responses of 5-hydroxytryptamine in the feline pulmonary vascular bed are mediated by two different 5-hydroxytryptamine receptors.
      C F Neely, D Haile and I Matot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1315-1326;

  2. Hamel, F G

    1. Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
      H Chen, F G Hamel, G Siford and W C Duckworth
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1293-1298;

  3. Harris, D N

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  4. Harrison, N L

    1. Trichloroethanol potentiates synaptic transmission mediated by gamma-aminobutyric acidA receptors in hippocampal neurons.
      D M Lovinger, S A Zimmerman, M Levitin, M V Jones and N L Harrison
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1097-1103;

  5. Hatmi, M

    1. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
      C Mounier, M Hatmi, A Faili, C Bon and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1460-1467;

  6. Hatzidimitriou, G

    1. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
      C R Scanzello, G Hatzidimitriou, A L Martello, J L Katz and G A Ricaurte
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1484-1491;

  7. Haycock, D A

    1. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
      J E Kuster, J I Stevenson, S J Ward, T E D'Ambra and D A Haycock
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1352-1363;

  8. Hechler, V

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  9. Hedberg, A

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  10. Hietala, J

    1. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
      M Kuoppamäki, T Seppälä, E Syvälahti and J Hietala
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1262-1267;

  11. Higgins, G A

    1. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
      G A Higgins, N Joharchi and E M Sellers
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1440-1449;

  12. Higgins, S T

    1. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
      C R Rush, S T Higgins, W K Bickel and J R Hughes
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1218-1226;

  13. Hiramatsu, M

    1. A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine.
      A K Cho, M Hiramatsu, D A Schmitz, H M Vargas and E M Landaw
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1401-1405;

  14. Hughes, J R

    1. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
      C R Rush, S T Higgins, W K Bickel and J R Hughes
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1218-1226;

I

  1. Inturrisi, C E

    1. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
      P J Tiseo and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1090-1096;

  2. Ishizaki, T

    1. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
      H Echizen, H Kawasaki, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1425-1431;

J

  1. Jakubovic, A

    1. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
      G S Robertson, C S Tham, C Wilson, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1344-1351;

  2. Jia, H

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  3. Jiang, Q

    1. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
      Q Jiang, A Seyed-Mozaffari, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1021-1027;

  4. Joharchi, N

    1. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
      G A Higgins, N Joharchi and E M Sellers
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1440-1449;

  5. Jones, M V

    1. Trichloroethanol potentiates synaptic transmission mediated by gamma-aminobutyric acidA receptors in hippocampal neurons.
      D M Lovinger, S A Zimmerman, M Levitin, M V Jones and N L Harrison
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1097-1103;

  6. Junien, J L

    1. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
      P J Riviere, R K Rao, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1268-1274;

  7. Juul, B

    1. Effects of ATP and related nucleotides on the tone of isolated rat mesenteric resistance arteries.
      B Juul, L Plesner and C Aalkjaer
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1234-1240;

K

  1. Kadowitz, P J

    1. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
      S Y Osei, R K Minkes, J A Bellan and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1104-1112;

  2. Kalsner, S

    1. Cocaine sensitization of coronary artery contractions: mechanism of drug-induced spasm.
      S Kalsner
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1132-1140;

  3. Katz, J L

    1. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
      C R Scanzello, G Hatzidimitriou, A L Martello, J L Katz and G A Ricaurte
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1484-1491;

  4. Kawasaki, H

    1. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
      H Echizen, H Kawasaki, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1425-1431;

  5. Krecic, M E

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  6. Kroboth, P D

    1. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.
      P D Kroboth, R J Bertz and R B Smith
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1047-1055;

  7. Kucharczyk, N

    1. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
      R T McCabe, C G Wasterlain, N Kucharczyk, R D Sofia and J R Vogel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1248-1252;

  8. Kuenzli, K A

    1. Adenosine-stimulated contraction in nonpregnant guinea pig myometrium does not involve cyclooxygenase.
      M E Bradley, K A Kuenzli and I L Buxton
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1033-1039;

  9. Kuoppamäki, M

    1. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
      M Kuoppamäki, T Seppälä, E Syvälahti and J Hietala
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1262-1267;

  10. Kuster, J E

    1. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
      J E Kuster, J I Stevenson, S J Ward, T E D'Ambra and D A Haycock
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1352-1363;

L

  1. Landaw, E M

    1. A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine.
      A K Cho, M Hiramatsu, D A Schmitz, H M Vargas and E M Landaw
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1401-1405;

  2. Law, P Y

    1. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
      C L Bergsbaken, S L Sommers and P Y Law
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1474-1483;

  3. Lecci, A

    1. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
      A Lecci, S Giuliani, R Patacchini and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1327-1332;

  4. Lehnert, S

    1. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
      M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;

  5. Le Marouille-Girardon, S

    1. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
      M J Millan, J M Rivet, H Canton, S Le Marouille-Girardon and A Gobert
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1364-1376;

  6. Levin, G

    1. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
      S Nowicki, G Levin and M A Enero
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1377-1380;

  7. Levitin, M

    1. Trichloroethanol potentiates synaptic transmission mediated by gamma-aminobutyric acidA receptors in hippocampal neurons.
      D M Lovinger, S A Zimmerman, M Levitin, M V Jones and N L Harrison
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1097-1103;

  8. Li, Z

    1. Acute effects of nicotine on rat mesenteric vasculature and tail artery.
      Z Li and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1305-1310;

  9. Liewer, S A

    1. Bicarbonate induces sensitization of cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
      M L Toews, L J Arneson-Rotert and S A Liewer
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1211-1217;

  10. Liu, E C

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  11. Liu, Z

    1. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
      Z Liu, J F Brien, G S Marks, B E McLaughlin and K Nakatsu
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1432-1439;

  12. Lovinger, D M

    1. Trichloroethanol potentiates synaptic transmission mediated by gamma-aminobutyric acidA receptors in hippocampal neurons.
      D M Lovinger, S A Zimmerman, M Levitin, M V Jones and N L Harrison
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1097-1103;

M

  1. Maggi, C A

    1. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
      A Lecci, S Giuliani, R Patacchini and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1327-1332;

  2. Maitre, M

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  3. Mark, J

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  4. Marks, G S

    1. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
      Z Liu, J F Brien, G S Marks, B E McLaughlin and K Nakatsu
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1432-1439;

  5. Martello, A L

    1. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
      C R Scanzello, G Hatzidimitriou, A L Martello, J L Katz and G A Ricaurte
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1484-1491;

  6. Martin, I

    1. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
      A Miralles, G Olmos, M Sastre, F Barturen, I Martin and J A Garcia-Sevilla
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1187-1197;

  7. Matot, I

    1. Tone-dependent responses of 5-hydroxytryptamine in the feline pulmonary vascular bed are mediated by two different 5-hydroxytryptamine receptors.
      C F Neely, D Haile and I Matot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1315-1326;

  8. Maxwell, D M

    1. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
      D M Maxwell, K M Brecht, B P Doctor and A D Wolfe
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1085-1089;

  9. McCabe, R T

    1. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
      R T McCabe, C G Wasterlain, N Kucharczyk, R D Sofia and J R Vogel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1248-1252;

  10. McKelvy, J F

    1. Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.
      J A Firestone, G A Gerhardt, J F DeBernardis, J F McKelvy and M D Browning
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1206-1210;

  11. McLaughlin, B E

    1. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
      Z Liu, J F Brien, G S Marks, B E McLaughlin and K Nakatsu
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1432-1439;

  12. Mignot, E

    1. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
      S Nishino, B Fruhstorfer, J Arrigoni, C Guilleminault, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1079-1084;

  13. Millan, M J

    1. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
      M J Millan, J M Rivet, H Canton, S Le Marouille-Girardon and A Gobert
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1364-1376;

  14. Minkes, R K

    1. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
      S Y Osei, R K Minkes, J A Bellan and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1104-1112;

  15. Miralles, A

    1. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
      A Miralles, G Olmos, M Sastre, F Barturen, I Martin and J A Garcia-Sevilla
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1187-1197;

  16. Misra, R N

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  17. Miyamoto, Y

    1. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
      Y Miyamoto, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1141-1145;

  18. Monshizadegan, H

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  19. Morrone, L A

    1. Effect of nonsteroidal anti-inflammatory drugs on withdrawal responses in guinea pig ileum after a brief exposure to morphine.
      P Valeri, L A Morrone, L Romanelli and M C Amico
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1028-1032;

  20. Mounier, C

    1. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
      C Mounier, M Hatmi, A Faili, C Bon and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1460-1467;

  21. Murray, T F

    1. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility.
      G Zhang, P H Franklin and T F Murray
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1415-1424;

N

  1. Nakane, T

    1. Pharmacological analysis of vasodilation induced by extracellular adenosine 3',5'-cyclic monophosphate in the isolated and perfused canine coronary artery.
      T Nakane and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1253-1261;

  2. Nakatsu, K

    1. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
      Z Liu, J F Brien, G S Marks, B E McLaughlin and K Nakatsu
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1432-1439;

  3. Nattel, S

    1. Potassium channel blocking properties of propafenone in rabbit atrial myocytes.
      D Duan, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1113-1123;
    2. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity.
      S Ranger, R Sheldon, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1160-1167;

  4. Neely, C F

    1. Tone-dependent responses of 5-hydroxytryptamine in the feline pulmonary vascular bed are mediated by two different 5-hydroxytryptamine receptors.
      C F Neely, D Haile and I Matot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1315-1326;

  5. Nirei, H

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  6. Nishino, S

    1. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
      S Nishino, B Fruhstorfer, J Arrigoni, C Guilleminault, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1079-1084;

  7. Nomoto, A

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  8. Notsu, Y

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  9. Nowicki, S

    1. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
      S Nowicki, G Levin and M A Enero
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1377-1380;

O

  1. O'Donnell, J M

    1. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate.
      J M O'Donnell
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1168-1178;

  2. Olmos, G

    1. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
      A Miralles, G Olmos, M Sastre, F Barturen, I Martin and J A Garcia-Sevilla
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1187-1197;

  3. Ono, T

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  4. Osei, S Y

    1. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
      S Y Osei, R K Minkes, J A Bellan and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1104-1112;

P

  1. Pascaud, X

    1. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
      P J Riviere, R K Rao, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1268-1274;

  2. Patacchini, R

    1. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
      A Lecci, S Giuliani, R Patacchini and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1327-1332;

  3. Paul, D

    1. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity.
      D J Carr, B M Gebhardt and D Paul
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1179-1186;

  4. Peter, P

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  5. Plesner, L

    1. Effects of ATP and related nucleotides on the tone of isolated rat mesenteric resistance arteries.
      B Juul, L Plesner and C Aalkjaer
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1234-1240;

  6. Porreca, F

    1. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
      P J Riviere, R K Rao, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1268-1274;

  7. Portoghese, P S

    1. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
      Y Miyamoto, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1141-1145;

  8. Proud, D

    1. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
      D Proud, C J Reynolds, J Broomfield, D W Goldman and J M Bathon
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1124-1131;

R

  1. Ranger, S

    1. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity.
      S Ranger, R Sheldon, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1160-1167;

  2. Rao, R K

    1. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
      P J Riviere, R K Rao, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1268-1274;

  3. Reynolds, C J

    1. Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140.
      D Proud, C J Reynolds, J Broomfield, D W Goldman and J M Bathon
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1124-1131;

  4. Ricaurte, G A

    1. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
      C R Scanzello, G Hatzidimitriou, A L Martello, J L Katz and G A Ricaurte
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1484-1491;

  5. Riker, W K

    1. Cholinergic and anticholinergic drug effects on survival during hypoxia: significant gender differences.
      M Saiyed and W K Riker
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1146-1153;

  6. Ritz, M C

    1. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites.
      M C Ritz and F R George
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1333-1343;

  7. Rivet, J M

    1. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
      M J Millan, J M Rivet, H Canton, S Le Marouille-Girardon and A Gobert
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1364-1376;

  8. Riviere, P J

    1. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
      P J Riviere, R K Rao, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1268-1274;

  9. Robertson, G S

    1. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
      G S Robertson, C S Tham, C Wilson, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1344-1351;

  10. Romanelli, L

    1. Effect of nonsteroidal anti-inflammatory drugs on withdrawal responses in guinea pig ileum after a brief exposure to morphine.
      P Valeri, L A Morrone, L Romanelli and M C Amico
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1028-1032;

  11. Rush, C R

    1. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
      C R Rush, S T Higgins, W K Bickel and J R Hughes
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1218-1226;

  12. Rustum, Y M

    1. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
      M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;

S

  1. Sabra, R

    1. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
      B C Abels, R A Branch and R Sabra
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1285-1292;

  2. Saiyed, M

    1. Cholinergic and anticholinergic drug effects on survival during hypoxia: significant gender differences.
      M Saiyed and W K Riker
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1146-1153;

  3. Sakakibara, Y

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  4. Sastre, M

    1. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
      A Miralles, G Olmos, M Sastre, F Barturen, I Martin and J A Garcia-Sevilla
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1187-1197;

  5. Scanzello, C R

    1. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
      C R Scanzello, G Hatzidimitriou, A L Martello, J L Katz and G A Ricaurte
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1484-1491;

  6. Scarpace, P J

    1. Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: role of phosphodiesterase.
      B S Bender, W E Bell, S Taylor and P J Scarpace
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1381-1386;

  7. Schecter, R L

    1. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
      M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;

  8. Schilling, W P

    1. Role of lipid peroxidation in tert-butylhydroperoxide-induced inhibition of endothelial cell calcium signaling.
      S J Elliott, T N Doan and W P Schilling
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1063-1070;

  9. Schmitt, M

    1. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
      V Hechler, P Peter, S Gobaille, J J Bourguignon, M Schmitt, J D Ehrhardt, J Mark and M Maitre
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1406-1414;

  10. Schmitz, D A

    1. A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine.
      A K Cho, M Hiramatsu, D A Schmitz, H M Vargas and E M Landaw
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1401-1405;

  11. Schneider, H H

    1. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
      K G Steppuhn, H H Schneider, L Turski and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1395-1400;

  12. Sellers, E M

    1. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
      G A Higgins, N Joharchi and E M Sellers
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1440-1449;

  13. Seppälä, T

    1. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
      M Kuoppamäki, T Seppälä, E Syvälahti and J Hietala
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1262-1267;

  14. Seyed-Mozaffari, A

    1. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
      Q Jiang, A Seyed-Mozaffari, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1021-1027;

  15. Sheldon, R

    1. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity.
      S Ranger, R Sheldon, B Fermini and S Nattel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1160-1167;

  16. Shepard, D R

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  17. Shoubo, M

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  18. Siford, G

    1. Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
      H Chen, F G Hamel, G Siford and W C Duckworth
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1293-1298;

  19. Singer, D H

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  20. SLAWSKY, MARA T.

    1. Characterization of 4-Aminopyridine Block of the Transient Outward K+ Current in Adult Rat Ventricular Myocytes
      NEIL A. CASTLE and MARA T. SLAWSKY
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1450-1459;

  21. Smith, R B

    1. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.
      P D Kroboth, R J Bertz and R B Smith
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1047-1055;

  22. Sofia, R D

    1. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
      R T McCabe, C G Wasterlain, N Kucharczyk, R D Sofia and J R Vogel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1248-1252;

  23. Sogabe, K

    1. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
      K Sogabe, H Nirei, M Shoubo, A Nomoto, S Ao, Y Notsu and T Ono
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1040-1046;

  24. Sommers, S L

    1. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
      C L Bergsbaken, S L Sommers and P Y Law
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1474-1483;

  25. Stephens, D N

    1. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
      K G Steppuhn, H H Schneider, L Turski and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1395-1400;

  26. Steppuhn, K G

    1. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
      K G Steppuhn, H H Schneider, L Turski and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1395-1400;

  27. Stern, L S

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  28. Stevenson, J I

    1. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
      J E Kuster, J I Stevenson, S J Ward, T E D'Ambra and D A Haycock
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1352-1363;

  29. Syvälahti, E

    1. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
      M Kuoppamäki, T Seppälä, E Syvälahti and J Hietala
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1262-1267;

T

  1. Takemori, A E

    1. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
      Y Miyamoto, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1141-1145;

  2. Takenaka, T

    1. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
      T Takenaka, H Forster and M Epstein
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1154-1159;

  3. Tani, M

    1. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
      H Echizen, H Kawasaki, K Chiba, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1425-1431;

  4. Taylor, S

    1. Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: role of phosphodiesterase.
      B S Bender, W E Bell, S Taylor and P J Scarpace
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1381-1386;

  5. Tham, C S

    1. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
      G S Robertson, C S Tham, C Wilson, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1344-1351;

  6. Tiseo, P J

    1. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
      P J Tiseo and C E Inturrisi
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1090-1096;

  7. Toews, M L

    1. Bicarbonate induces sensitization of cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
      M L Toews, L J Arneson-Rotert and S A Liewer
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1211-1217;

  8. Trachte, G J

    1. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
      G J Trachte
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1227-1233;

  9. Turski, L

    1. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
      K G Steppuhn, H H Schneider, L Turski and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1395-1400;

V

  1. Valeri, P

    1. Effect of nonsteroidal anti-inflammatory drugs on withdrawal responses in guinea pig ileum after a brief exposure to morphine.
      P Valeri, L A Morrone, L Romanelli and M C Amico
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1028-1032;

  2. Vargaftig, B B

    1. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
      C Mounier, M Hatmi, A Faili, C Bon and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1460-1467;

  3. Vargas, H M

    1. A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine.
      A K Cho, M Hiramatsu, D A Schmitz, H M Vargas and E M Landaw
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1401-1405;

  4. Vogel, J R

    1. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
      R T McCabe, C G Wasterlain, N Kucharczyk, R D Sofia and J R Vogel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1248-1252;

W

  1. Walker, M

    1. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
      G Apseloff, B Girten, M Walker, D R Shepard, M E Krecic, L S Stern and N Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1071-1078;

  2. Wang, L

    1. Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle.
      L Wang, N Chiamvimonvat and H J Duff
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1056-1062;

  3. Ward, S J

    1. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
      J E Kuster, J I Stevenson, S J Ward, T E D'Ambra and D A Haycock
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1352-1363;

  4. Wasserstrom, J A

    1. Characteristics of lidocaine block of sodium channels in single human atrial cells.
      H Jia, T Furukawa, D H Singer, Y Sakakibara, S Eager, C Backer, C Arentzen and J A Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1275-1284;

  5. Wasterlain, C G

    1. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
      R T McCabe, C G Wasterlain, N Kucharczyk, R D Sofia and J R Vogel
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1248-1252;

  6. Webb, M L

    1. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
      M L Webb, E C Liu, H Monshizadegan, A Hedberg, R N Misra, H Goldenberg and D N Harris
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1387-1394;

  7. Wilson, C

    1. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
      G S Robertson, C S Tham, C Wilson, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1344-1351;

  8. Wolfe, A D

    1. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
      D M Maxwell, K M Brecht, B P Doctor and A D Wolfe
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1085-1089;

  9. Wu, D

    1. Induction of liver cytochrome P4502E1 by pyrazole and 4-methylpyrazole in neonatal rats.
      D Wu and A I Cederbaum
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1468-1473;

Z

  1. Zhang, G

    1. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility.
      G Zhang, P H Franklin and T F Murray
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1415-1424;

  2. Zimmerman, S A

    1. Trichloroethanol potentiates synaptic transmission mediated by gamma-aminobutyric acidA receptors in hippocampal neurons.
      D M Lovinger, S A Zimmerman, M Levitin, M V Jones and N L Harrison
      Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1097-1103;
Back to top

In this issue